FORMULATION OF FLUCONAZOLE AS TOPICAL ANTIFUNGAL GELS BY MICROSPONGE BASED DELIVERY SYSTEMS
The purpose of present work was to formulate Fluconazole loaded microsponge-based topical delivery system for modified release. Microsponges with varied drug–polymer ratios were prepared by emulsion solvent diffusion technique using Ethyl cellulose as release retard material. Prepared microsponges were studied for particle size and physical characterization. Scanning electron microscopy (SEM) images showed the microsponges porous and spherical in shape. The microsponges were then incorporated in carbopol gel and evaluated for pH, viscosity, spreadability, drug content, in-vitro release. The In vitro drug release showed that microsponges with 1:1.5 drug–polymer ratios (F3) were more efficient to give sustained release of 74.2% at the end of 8 hr. All the microsponge gel formulations (i.e.F1- F10) showed better results like pH between 6.5-7.0, viscosity between 25,030-47,390 cps, spreadability 2-4 cm/s and drug content of 76.20±0.02% to 96.41±0.01%. Hence, the fabricated microsponge based formulation of Fluconazole would be anticipation and promising substitute to conventional therapy of skin infections.
Costa P., Lobo JMS. 2001. Modeling and comparison of dissolution profiles. Europ J Pharm Sci. v13, p123-133.
D’souza JI., More HN., 2008. Topical anti-inflammatory gels of fluocinolone acetonide entrapped in eudragit based microsponge delivery system. Res. J. Pharm. Technol. v1, p502–506,
Doaa A., Helal, El-Rhman DA., Abdel-Halim SA., Mohamed A., El-Nabarawi 2015. Formulation and evaluation of Fluconazole topical gel Int J Pharm Pharm Sci, v4, (Suppl 5), p176-183,
El-Houssieny B., Hamouda HM. 2010. Formul-ation and evaluation of clotrimazole from pluronic F127 gels. Drug discovery and therapeutics; v4(1), p33-43
Farhan JA., Mohd AA., Zeenat IK., Roop KK., Mushir A. 2008 Development and in vitro evaluatiaon of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Acta Pharm. v58: p407-419,
Harish NM., Prabhu P., Subrahmanyam EVS. 2009. Formulation and evaluation of in situ gels containing clotrimazole for oral candidiasis. Indian J Pharm Sci v71(4) p 421–427
Kilicarslan M., Baykara T., 2003. The effect of the drug/polymer ratio on the properties of verapamil hydrochloride loaded micro-spheres. Int. J. Pharm. v252, p99–109
Kulkarni RV., Wagh YJ., Setty CM., Sa B., 2011. Development and characterization of sodium alginate hydroxypropyl methylcellulose-polyester multilayered hydrogel membranes for drug delivery through the skin. Polym.-Plast. Technol. Eng. v50, p490–497,
Lee J-H., Park TG., Choi HK., 1999. Development of oral drug delivery system using floating microspheres. J. Microencapsul. v16 p715–729
Mine O., Erdal C., Ahmet A., 2006. Design and evaluation of colon specific drug delivery system containing flurbiprofen micros-ponges. Int. J. Pharm. v318, p103–117,
Neha G., Tomar N., Nagaich U., 2016. Miconazole Microsponges based topical delivery system for diaper dermatitis. Ars Pharm. v57(2): p77-87
Niethard FU., Gold MS., Solomon GS., Liu JM., Unkauf M., Albrecht HH., Elkik F., 2005. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J. Rheumatol. v32, p2384–2392,
Nokhodchi A., Jelvehgari M., Reza SM., Reza MM., 2007. Factors affecting the morphology of benzoyl peroxide microsponges. Micron v38, p834–840,
Orlu M., Cevher E., Araman A. 2006 Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int JPharm. v318 p103–17,
Roaa AN., Ahmed AH., 2014 Preparation and Evaluation of Meloxicam Microsponges as Transdermal Delivery System Iraqi J Pharm Sc v23(2), p62-74
Vinod LG., Vishal DY., Rakesh PD., Prafulla BC., Swapnil DJ. 2012. 'Effect of Carbopol 934 and 940 on Fluconazole Release from Topical Gel Formulation', C.P.R. 2(2) p.487- 493,
Vyas LK., Tapar KK., Laddha BH., Lahoti AO., Nema RK., 2010. Formulation and development of anti-blemish preparations using microsponge technology. J. Chem. Pharm. Res. v2, p562–571,
Vyas SP., Khar RK., 2002. Targeted and Controlled Drug Delivery Novel Carrier System, 1st ed. CBS Publication, New Delhi
Won R. 1987. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen. U.S. Patent 4,690,825
Rizkalla ZCM., Aziz, LR., Soliman II., 2011. In-vitro and in vivo evaluation of hydroxyzine hydrochloride microsponges for topical delivery. AAPS Pharm. Sci. Technol. v12, p989–1001.
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by:
View My Stats